Trial Outcomes & Findings for Cardiometabolic Effects of Pecans as a Snack (NCT NCT05071807)

NCT ID: NCT05071807

Last Updated: 2025-02-25

Results Overview

Measured by brachial ultrasound and expressed as percentage points of change in arterial diameter

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

138 participants

Primary outcome timeframe

12 weeks

Results posted on

2025-02-25

Participant Flow

Participant milestones

Participant milestones
Measure
Pecan Group
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
Overall Study
STARTED
69
69
Overall Study
COMPLETED
62
68
Overall Study
NOT COMPLETED
7
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Pecan Group
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
Overall Study
Withdrawal by Subject
4
0
Overall Study
Unrelated medical issues
3
0
Overall Study
Relocated
0
1

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Pecan Group
n=69 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=69 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
Total
n=138 Participants
Total of all reporting groups
Age, Continuous
46 years
STANDARD_DEVIATION 12 • n=69 Participants
46 years
STANDARD_DEVIATION 14 • n=69 Participants
46 years
STANDARD_DEVIATION 13 • n=138 Participants
Sex: Female, Male
Female
45 Participants
n=69 Participants
36 Participants
n=69 Participants
81 Participants
n=138 Participants
Sex: Female, Male
Male
24 Participants
n=69 Participants
33 Participants
n=69 Participants
57 Participants
n=138 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
69 participants
n=69 Participants
69 participants
n=69 Participants
138 participants
n=138 Participants
Weight
84.3 kg
STANDARD_DEVIATION 12.5 • n=69 Participants
85.2 kg
STANDARD_DEVIATION 14.3 • n=69 Participants
84.8 kg
STANDARD_DEVIATION 13.4 • n=138 Participants
Waist circumference
97.2 cm
STANDARD_DEVIATION 8.8 • n=69 Participants
98.8 cm
STANDARD_DEVIATION 10.8 • n=69 Participants
98.0 cm
STANDARD_DEVIATION 9.9 • n=138 Participants
Pulse wave velocity
7.1 m/s
STANDARD_DEVIATION 1.3 • n=69 Participants
7.2 m/s
STANDARD_DEVIATION 1.2 • n=69 Participants
7.2 m/s
STANDARD_DEVIATION 1.3 • n=138 Participants
Flow mediated dilation
7.2 percent point change in arterial diamete
STANDARD_DEVIATION 4.0 • n=69 Participants
6.1 percent point change in arterial diamete
STANDARD_DEVIATION 3.3 • n=69 Participants
6.6 percent point change in arterial diamete
STANDARD_DEVIATION 3.7 • n=138 Participants
LDL-C
118 mg/dL
STANDARD_DEVIATION 34 • n=69 Participants
116 mg/dL
STANDARD_DEVIATION 28 • n=69 Participants
117 mg/dL
STANDARD_DEVIATION 31 • n=138 Participants
HDL-C
54 mmHg
STANDARD_DEVIATION 14 • n=69 Participants
52 mmHg
STANDARD_DEVIATION 13 • n=69 Participants
53 mmHg
STANDARD_DEVIATION 13.4 • n=138 Participants
Triglycerides
109 mmHg
STANDARD_DEVIATION 67 • n=69 Participants
116 mmHg
STANDARD_DEVIATION 47 • n=69 Participants
113 mmHg
STANDARD_DEVIATION 58 • n=138 Participants
LDL subclasses
Large
373 nmol/L
STANDARD_DEVIATION 251 • n=69 Participants
329 nmol/L
STANDARD_DEVIATION 194 • n=69 Participants
351 nmol/L
STANDARD_DEVIATION 225 • n=138 Participants
LDL subclasses
Medium
366 nmol/L
STANDARD_DEVIATION 267 • n=69 Participants
312 nmol/L
STANDARD_DEVIATION 255 • n=69 Participants
339 nmol/L
STANDARD_DEVIATION 261 • n=138 Participants
LDL subclasses
Small
623 nmol/L
STANDARD_DEVIATION 435 • n=69 Participants
698 nmol/L
STANDARD_DEVIATION 353 • n=69 Participants
660 nmol/L
STANDARD_DEVIATION 396 • n=138 Participants
LDL subclasses
Total LDL particle count
1362 nmol/L
STANDARD_DEVIATION 399 • n=69 Participants
1339 nmol/L
STANDARD_DEVIATION 339 • n=69 Participants
1350 nmol/L
STANDARD_DEVIATION 396 • n=138 Participants
HDL subclasses
Large
2.5 µmol/L
STANDARD_DEVIATION 1.7 • n=69 Participants
2.3 µmol/L
STANDARD_DEVIATION 1.4 • n=69 Participants
2.4 µmol/L
STANDARD_DEVIATION 1.6 • n=138 Participants
HDL subclasses
Medium
4.0 µmol/L
STANDARD_DEVIATION 1.8 • n=69 Participants
4.4 µmol/L
STANDARD_DEVIATION 2.4 • n=69 Participants
4.2 µmol/L
STANDARD_DEVIATION 2.1 • n=138 Participants
HDL subclasses
Small
14.2 µmol/L
STANDARD_DEVIATION 2.8 • n=69 Participants
14.0 µmol/L
STANDARD_DEVIATION 3.4 • n=69 Participants
14.1 µmol/L
STANDARD_DEVIATION 3.1 • n=138 Participants
HDL subclasses
HDL total particle count
20.7 µmol/L
STANDARD_DEVIATION 2.6 • n=69 Participants
20.6 µmol/L
STANDARD_DEVIATION 2.9 • n=69 Participants
20.7 µmol/L
STANDARD_DEVIATION 2.7 • n=138 Participants
Brachial blood pressure
Systolic
124 mmHg
STANDARD_DEVIATION 15 • n=69 Participants
125 mmHg
STANDARD_DEVIATION 11 • n=69 Participants
124 mmHg
STANDARD_DEVIATION 13 • n=138 Participants
Brachial blood pressure
Diastolic
79 mmHg
STANDARD_DEVIATION 8 • n=69 Participants
79 mmHg
STANDARD_DEVIATION 10 • n=69 Participants
79 mmHg
STANDARD_DEVIATION 9 • n=138 Participants
Central blood pressure
Systolic
114 mmHg
STANDARD_DEVIATION 14 • n=69 Participants
114 mmHg
STANDARD_DEVIATION 14 • n=69 Participants
114 mmHg
STANDARD_DEVIATION 12 • n=138 Participants
Central blood pressure
Diastolic
79 mmHg
STANDARD_DEVIATION 10 • n=69 Participants
80 mmHg
STANDARD_DEVIATION 8 • n=69 Participants
80 mmHg
STANDARD_DEVIATION 9 • n=138 Participants
Augmentation index @ 75bpm
22 percentage of aortic pulse pressure
STANDARD_DEVIATION 11 • n=69 Participants
21 percentage of aortic pulse pressure
STANDARD_DEVIATION 13 • n=69 Participants
22 percentage of aortic pulse pressure
STANDARD_DEVIATION 12 • n=138 Participants
Plasma glucose
97 mg/dL
STANDARD_DEVIATION 7 • n=69 Participants
98 mg/dL
STANDARD_DEVIATION 8 • n=69 Participants
98 mg/dL
STANDARD_DEVIATION 7.4 • n=138 Participants
Serum insulin
9.4 μIU/mL
STANDARD_DEVIATION 5.0 • n=69 Participants
8.8 μIU/mL
STANDARD_DEVIATION 3.5 • n=69 Participants
9.1 μIU/mL
STANDARD_DEVIATION 4.3 • n=138 Participants
HbA1C
5.5 percentage of glycated hemoglobin
STANDARD_DEVIATION 0.3 • n=69 Participants
5.5 percentage of glycated hemoglobin
STANDARD_DEVIATION 0.3 • n=69 Participants
5.5 percentage of glycated hemoglobin
STANDARD_DEVIATION 0.3 • n=138 Participants
Diet quality: Healthy Eating Index 2020
57.2 scores on a scale
STANDARD_DEVIATION 13.4 • n=69 Participants
55.1 scores on a scale
STANDARD_DEVIATION 10.7 • n=69 Participants
56.1 scores on a scale
STANDARD_DEVIATION 12.1 • n=138 Participants
Total Cholesterol concentration
194 mg/dL
STANDARD_DEVIATION 39 • n=69 Participants
190 mg/dL
STANDARD_DEVIATION 32 • n=69 Participants
192 mg/dL
STANDARD_DEVIATION 36 • n=138 Participants

PRIMARY outcome

Timeframe: 12 weeks

Measured by brachial ultrasound and expressed as percentage points of change in arterial diameter

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=67 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
Flow Mediated Dilation
7.07 percent point change in arterial diamete
Standard Error 0.35
7.25 percent point change in arterial diamete
Standard Error 0.33

SECONDARY outcome

Timeframe: 12 weeks

Assessed from fasting blood draw expressed in mg/dL

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
LDL-cholesterol Concentration
110 mg/dL
Standard Error 1.35
117 mg/dL
Standard Error 1.26

SECONDARY outcome

Timeframe: 12 weeks

Assessed from fasting blood draw expressed in mg/dL

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
HDL-cholesterol Concentration
54 mg/dL
Standard Error 0.47
53 mg/dL
Standard Error 0.44

SECONDARY outcome

Timeframe: 12 weeks

Assessed from fasting blood draw expressed in mg/dL

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
Triglycerides
97.7 mg/dL
Interval 92.6 to 103.0
108 mg/dL
Interval 103.0 to 114.0

SECONDARY outcome

Timeframe: 12 weeks

Assessed from fasting blood draw expressed in nmol/L. Data were log transformed and back transformed to improve residual distribution; Measure Description: LDL particle size classifications are as follows: 22-25.5 nm is small, 25.6-26.5 nm medium, and 26.6-28.5 nm large. Typically, smaller LDL is associated with increased cardiovascular risk compared to larger.

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
LDL Lipoprotein Subclasses
Large
281 nmol/L
Interval 249.0 to 317.0
252 nmol/L
Interval 225.0 to 281.0
LDL Lipoprotein Subclasses
Total
1248 nmol/L
Interval 1216.0 to 1280.0
1304 nmol/L
Interval 1273.0 to 1336.0

SECONDARY outcome

Timeframe: 12 weeks

Assessed from fasting blood draw expressed in µmol/L; Measure Description: Size classifications of HDL subclasses are as follows: large (size 9.4-14.0 nm), medium (8.3-9.3 nm), and small (7.3-8.2 nm). Higher levels of large HDL may be inversely related to cardiovascular risk.

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
HDL Lipoprotein Subclasses
Medium
4.1 μmol/L
Standard Error 0.1
4.4 μmol/L
Standard Error 0.1
HDL Lipoprotein Subclasses
Small
14.1 μmol/L
Standard Error 0.2
14.3 μmol/L
Standard Error 0.2
HDL Lipoprotein Subclasses
Total
21.0 μmol/L
Standard Error 0.17
21.0 μmol/L
Standard Error 0.16

SECONDARY outcome

Timeframe: 12 weeks

Blood pressure measured assessed using a SphygmoCor Xcel (Atcor Medical)

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
Brachial Systolic and Diastolic Blood Pressure
Systolic
125 mmHg
Standard Error 0.81
125 mmHg
Standard Error 0.77
Brachial Systolic and Diastolic Blood Pressure
Diastolic
79 mmHg
Standard Error 0.50
79 mmHg
Standard Error 0.47

SECONDARY outcome

Timeframe: 12 weeks

Blood pressure measured assessed using a SphygmoCor Xcel (Atcor Medical)

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
Central Systolic and Diastolic Blood Pressure
Systolic
114 mmHg
Standard Error 0.70
115 mmHg
Standard Error 0.69
Central Systolic and Diastolic Blood Pressure
Diastolic
80 mmHg
Standard Error 0.50
80 mmHg
Standard Error 0.48

SECONDARY outcome

Timeframe: 12 weeks

A measure of arterial stiffness assessed using a SphygmoCor Xcel (Atcor Medical). Expressed in meters/second. Higher values indicate greater arterial stiffness

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
Carotid-femoral Pulse Wave Velocity
7.1 m/s
Standard Deviation 1.3
7.3 m/s
Standard Deviation 1.3

SECONDARY outcome

Timeframe: 12 weeks

A measure of arterial stiffness assessed using a SphygmoCor Xcel (Atcor Medical). Expressed as a percentage. A higher percentage value is indicative of greater arterial stiffness. Measure Description: Augmentation index is a measure of arterial stiffening that correlates with CVD risk. Higher augmentation index, used as a surrogate for wave reflection, is indicative of additional load on the left ventricle. Augmentation index is calculated as augmentation pressure/pulse pressure\*100 to provide a percent. We utilized the Sphymocor Xcel for this measure. We used standardized augmentation index at 75 bpm for heart rate.

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
Augmentation Index@75bpm
21 percentage of aortic pulse pressure
Standard Error 0.65
22 percentage of aortic pulse pressure
Standard Error 0.65

SECONDARY outcome

Timeframe: 12 weeks

Fasting blood glucose assessed by blood draw and expressed in mg/dL

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
Fasting Plasma Glucose Concentration
97.7 mg/dL
Standard Error 0.48
96.7 mg/dL
Standard Error 0.45

SECONDARY outcome

Timeframe: 12 weeks

Fasting serum insulin levels assessed by blood draw and expressed in micro IU/m

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
Serum Insulin Concentration
8.42 μIU/mL
Interval 7.92 to 8.95
8.33 μIU/mL
Interval 7.87 to 8.83

SECONDARY outcome

Timeframe: 12-weeks

HbA1c assessed in whole blood collected during fasting

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
HbA1c
5.53 percentage of glycated hemoglobin
Standard Error 0.01
5.49 percentage of glycated hemoglobin
Standard Error 0.01

SECONDARY outcome

Timeframe: 12-weeks

Diet quality measured by 24-hour recalls will be assessed using Health Eating Index 2020 (HEI-2020) scores range from 0-100 with 100 indicating perfect adherence to dietary guidelines and 0 indicating no adherence. The HEI-2020 includes 13 components; 9 components are adequacy (i.e., consuming more results in a higher score), and 4 are moderation (i.e., consuming less results in a higher score). The HEI-2020 was calculated with the Statistical Analysis System (SAS) code from the National Cancer Institute.

Outcome measures

Outcome measures
Measure
Pecan Group
n=65 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=67 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
Diet Quality: Healthy Eating Index 2020
60.8 scores on a scale
Standard Error 1.1
51.5 scores on a scale
Standard Error 1.0

SECONDARY outcome

Timeframe: 12-weeks

Assessed from fasting blood draw expressed in mg/dL

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
Total Cholesterol Concentration
185 mg/dL
Standard Error 1.69
193 mg/dL
Standard Error 1.59

SECONDARY outcome

Timeframe: 12 weeks

LDL subclasses with normal distribution; Measure Description: LDL particle size classifications are as follows: 22-25.5 nm is small, 25.6-26.5 nm medium, and 26.6-28.5 nm large. Typically, smaller LDL is associated with increased cardiovascular risk compared to larger.

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
LDL Subclasses
Medium
297 nmol/L
Standard Error 20.2
337 nmol/L
Standard Error 19.1
LDL Subclasses
Small
684 nmol/L
Standard Error 24.5
677 nmol/L
Standard Error 23.2

SECONDARY outcome

Timeframe: 12 weeks

Measure was log transformed and back transformed to improve distribution; results for large HDL subclass are presented; Measure Description: Size classifications of HDL subclasses are as follows: large (size 9.4-14.0 nm), medium (8.3-9.3 nm), and small (7.3-8.2 nm). Higher levels of large HDL may be inversely related to cardiovascular risk.

Outcome measures

Outcome measures
Measure
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
HDL Subclass-Large
2.2 μmol/L
Interval 2.0 to 2.3
2.0 μmol/L
Interval 1.8 to 2.1

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 weeks

Abundance measured using 16 s rRNA sequencing

Outcome measures

Outcome data not reported

Adverse Events

Pecan Group

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Usual Care Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Pecan Group
n=69 participants at risk
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
Usual Care Group
n=69 participants at risk
Participants will consume their usual diet devoid of nuts Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
Gastrointestinal disorders
Appendectomy
1.4%
1/69 • Number of events 1 • 3 months
No deaths occurred no serious adverse events occurred.
0.00%
0/69 • 3 months
No deaths occurred no serious adverse events occurred.
Gastrointestinal disorders
Gastric resection
1.4%
1/69 • Number of events 1 • 3 months
No deaths occurred no serious adverse events occurred.
0.00%
0/69 • 3 months
No deaths occurred no serious adverse events occurred.

Additional Information

DCH Lab

Penn State University

Phone: 8148638056

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place